MSF LuxOR (@MSFLuxOR) header
MSF LuxOR (@MSFLuxOR) profile picture

Operational research for Médecins Sans Frontières, HQ in Luxembourg. Research for better care, better access and evidence to advocate. RTs ≠ endorsement

Luxembourg
Joined December 2013
Photo by MSF LuxOR (@MSFLuxOR)Photo by MSF LuxOR (@MSFLuxOR)Photo by MSF LuxOR (@MSFLuxOR)Photo by MSF LuxOR (@MSFLuxOR)Photo by MSF LuxOR (@MSFLuxOR)Photo by MSF LuxOR (@MSFLuxOR)Photo by MSF LuxOR (@MSFLuxOR)Photo by MSF LuxOR (@MSFLuxOR)Photo by MSF LuxOR (@MSFLuxOR)Photo by MSF LuxOR (@MSFLuxOR)
We're starting soon at CHL, Luxembourg! Keep tuned here to follow the discourse with Dr. Oumou Younouss, Dr. Gabriella Ferlazzo of @MSF_access, Joanna Ładomirska, and Dr. Anne Vergison of Lux Health div, moderated by @Ammer_B, organized by the MSF Foundation! @MSF_Luxembourg
1
4
518
Dr Sow answers on questions of queries. She responds with saying that we must mobilize all resources to tackle the problem of TB, get more support from partners and work with each other.
1
2
204
To conclude, @Ammer_B wraps the session with key takeaways: - knowledge generation and sharing of resources - better access to healthcare especially when on the move - determinants of health and ensuring access to patients - prices, lobbying, r&d - timely rx - political nature
1
149
MSF LuxOR retweeted
5 drug short treatment regimens could produce high rates of sustained treatment success for rifampicin-resistant tuberculosis (RR-TB). However, the longevity of these regimens will depend upon the rate at which resistance develops to the main components of the treatment & if patients with RR-TB require re-treatment. Comment @TheLancetInfDis ➡️doi.org/10.1016/S1473-3099(2… #RRTB #TB #EndTB #DRTB
9
12
806
The project has since evolved to broaden care to really ensure continuity of care - access to TB medicines, WHO standard implementation and patient centric approach.
1
1
81
MSF works closely with other stakeholders including @WHO_Europe to address the problem of TB in Poland, Germany, and beyond in Europe.
1
3
264